State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
NCT05905328 Phase 1, Phase 2
Recruiting
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Recei...
Condition
Cytokine Release Syndrome
Enrollment
54 pts
Location
United States
Sponsor
CytoAgents, Inc.
NCT06290128 Phase 3
Recruiting
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inf...
Condition
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Sanofi
NCT07061977 Phase 3
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemor...
Condition
Locally Advanced Cervical Adenocarcinoma
Enrollment
336 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06797245 N/A
Recruiting
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OA...
Condition
Overactive Bladder (OAB)
Enrollment
596 pts
Location
United States
Sponsor
Medstar Health Research Instit
NCT06658730 N/A
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With A...
Condition
Vascular Disease
Enrollment
1,500 pts
Location
United States, Denmark, France
Sponsor
W.L.Gore & Associates
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT07115329 Phase 2
Recruiting
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Majo...
Condition
Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc
NCT04718168 N/A
Recruiting
GORE® ENFORM Biomaterial Product Study
Condition
Hernia, Ventral
Enrollment
245 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06364280 N/A
Recruiting
Pediatric Prehospital Airway Resuscitation Trial
Condition
Heart Arrest, Out-Of-Hospital
Enrollment
3,000 pts
Location
United States
Sponsor
Ohio State University
NCT07045103 N/A
Recruiting
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Ar...
Condition
Lung Biopsy
Enrollment
900 pts
Location
United States
Sponsor
Invenio Imaging Inc.
NCT06859762 Phase 1
Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
220 pts
Location
United States, China
Sponsor
MediLink Therapeutics (Suzhou)
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06615050 Phase 3
Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosp...
Condition
Graft-versus-host Disease (GVHD)
Enrollment
572 pts
Location
United States
Sponsor
Incyte Corporation
NCT07214610 N/A
Recruiting
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cance...
Condition
Breast Cancer
Enrollment
3,300 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
NCT06767683 Phase 2, Phase 3
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypers...
Condition
Narcolepsy Type 1
Enrollment
256 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
NCT06919354 Phase 1
Recruiting
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Condition
Type 1 Diabetes (T1D)
Enrollment
16 pts
Location
United States
Sponsor
GentiBio, Inc
NCT05780502 N/A
Recruiting
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Low...
Condition
Musculoskeletal Injury
Enrollment
370 pts
Location
United States
Sponsor
Wake Forest University Health
NCT00900575 N/A
Recruiting
Cervical Cancer Detection Using Optical Spectroscopy
Condition
Cervical Cancer
Enrollment
350 pts
Location
United States
Sponsor
Duke University
NCT06868212 Phase 3
Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Time...
Condition
Chronic Spontaneous Urticaria (CSU)
Enrollment
400 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06960837 N/A
Recruiting
Ultrasound Simulation Case-based Workshop Implementation and Impact Assessment
Condition
Point-of-care Ultrasound
Enrollment
100 pts
Location
United States
Sponsor
Duke University
NCT06366282 N/A
Recruiting
Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
Condition
Traumatic Injury
Enrollment
24 pts
Location
United States
Sponsor
Wake Forest University Health
NCT05019625 N/A
Recruiting
Biomarker Development for Muscular Dystrophies
Condition
Myotonic Dystrophy
Enrollment
465 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT04711824 Phase 1, Phase 2
Recruiting
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Phys...
Condition
Breast Cancer
Enrollment
41 pts
Location
United States
Sponsor
Colette Shen
NCT06310291 EARLY_Phase 1
Recruiting
VTP-1000 in Adults With Celiac Disease
Condition
Celiac Disease
Enrollment
45 pts
Location
United States
Sponsor
Barinthus Biotherapeutics